CapsoVision (CV) Other Gross PP&E Adjustments (2024 - 2025)

CapsoVision's (CV) quarterly Other Gross PP&E Adjustments came in at -$1.8 million in Q4 2025, down 36.65% year-on-year from -$2.8 million in Q4 2024, and up 3.59% quarter-over-quarter from -$1.8 million in Q3 2025.

CapsoVision (CV) Other Gross PP&E Adjustments (2024 - 2025) Analysis & Trends

CapsoVision has disclosed Other Gross PP&E Adjustments across 2 years of filings, most recently posting -$1.8 million for Q4 2025.

  • Other Gross PP&E Adjustments for Q4 2025 came in at -$1.8 million, down 36.65% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.8 million (down 36.65% YoY), and the FY2025 annual result was -$1.8 million, down 36.65% from the prior year.
  • Other Gross PP&E Adjustments came in at -$1.8 million for Q4 2025 at CapsoVision, up from -$1.8 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$1.1 million in Q2 2025 to a low of -$1.8 million in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 23.14 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -405.00 Mn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -547.00 Mn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -99.30 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 5.30 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 2.39 Bn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 991.00 Mn
10 CapsoVision 176.55 Mn 166.44 Mn 1.95 Mn -1.77 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.77 Mn
Dec 31, 2025 -1.77 Mn
Sep 30, 2025 -1.84 Mn
Sep 30, 2025 -1.84 Mn
Jun 30, 2025 -1.13 Mn
Jun 30, 2025 -1.13 Mn
Dec 31, 2024 -1.30 Mn
Dec 31, 2024 -1.30 Mn